{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:38:24Z","timestamp":1793320704748,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,4]],"date-time":"2027-03-04T00:00:00Z","timestamp":1804118400000},"content-version":"am","delay-in-days":368,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["SCR_022380"],"award-info":[{"award-number":["SCR_022380"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AI045008"],"award-info":[{"award-number":["P30 AI045008"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["SCR_022376"],"award-info":[{"award-number":["SCR_022376"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AI191610"],"award-info":[{"award-number":["P01AI191610"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32AI007632"],"award-info":[{"award-number":["T32AI007632"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA016520"],"award-info":[{"award-number":["P30 CA016520"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["U19AI149680"],"award-info":[{"award-number":["U19AI149680"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["U19AI117950"],"award-info":[{"award-number":["U19AI117950"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI164570"],"award-info":[{"award-number":["UM1AI164570"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ymthe.2026.01.006","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T07:45:46Z","timestamp":1768031146000},"page":"1352-1366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical trial results provide the rationale to protect dual HIV-specific T cells with a signaling-defective HIV fusion inhibitor"],"prefix":"10.1016","volume":"34","author":[{"given":"Pablo","family":"Tebas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie K.","family":"Jadlowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Betina","family":"Pampena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sriram","family":"Srivatsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colby R.","family":"Maldini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chungdhak Jaming","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Haggarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Plesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avery L.","family":"Gaymon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Veloso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce L.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Putt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Kulikovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Fraietta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Betts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Hoxie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1057-576X","authenticated-orcid":false,"given":"James L.","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.01.006_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/417095a","article-title":"HIV preferentially infects HIV-specific CD4+ T cells","volume":"417","author":"Douek","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.01.006_bib2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/imr.12066","article-title":"CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure","volume":"254","author":"Okoye","year":"2013","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ymthe.2026.01.006_bib3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/infdis\/jiaa223","article-title":"Challenges and Opportunities of Using Adoptive T-Cell Therapy as Part of an HIV Cure Strategy","volume":"223","author":"Zhou","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ymthe.2026.01.006_bib4","doi-asserted-by":"crossref","first-page":"9870","DOI":"10.1073\/pnas.89.20.9870","article-title":"Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative Rev trans-activator","volume":"89","author":"Bevec","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.01.006_bib5","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000931","article-title":"RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma","volume":"2","author":"DiGiusto","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.01.006_bib6","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.ymthe.2004.03.005","article-title":"Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral load","volume":"9","author":"Humeau","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.01.006_bib7","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/jgm.705","article-title":"Long-term survival and concomitant gene expression of ribozyme-transduced CD4+ T-lymphocytes in HIV-infected patients","volume":"7","author":"Macpherson","year":"2005","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ymthe.2026.01.006_bib8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nm.1932","article-title":"Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells","volume":"15","author":"Mitsuyasu","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.01.006_bib9","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/mt.2009.316","article-title":"HIV sequence variation associated with env antisense adoptive T-cell therapy in the hNSG mouse model","volume":"18","author":"Mukherjee","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.01.006_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1743-422X-7-33","article-title":"A dual function TAR Decoy serves as an anti-HIV siRNA delivery vehicle","volume":"7","author":"Unwalla","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.ymthe.2026.01.006_bib11","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nbt1410","article-title":"Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases","volume":"26","author":"Perez","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.01.006_bib12","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1300662","article-title":"Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV","volume":"370","author":"Tebas","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.01.006_bib13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/QAI.0000000000001190","article-title":"TALEN-Mediated Knockout of CCR5 Confers Protection Against Infection of Human Immunodeficiency Virus","volume":"74","author":"Shi","year":"2017","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.ymthe.2026.01.006_bib14","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s41434-021-00271-9","article-title":"Optimisation of a TALE nuclease targeting the HIV co-receptor CCR5 for clinical application","volume":"28","author":"Schwarze","year":"2021","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2026.01.006_bib15","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nbt.2507","article-title":"Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease","volume":"31","author":"Cho","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.01.006_bib16","doi-asserted-by":"crossref","first-page":"9584","DOI":"10.1093\/nar\/gkt714","article-title":"CRISPR\/Cas9 systems targeting beta-globin and CCR5 genes have substantial off-target activity","volume":"41","author":"Cradick","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2026.01.006_bib17","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1097\/00002030-200212060-00002","article-title":"Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication","volume":"16","author":"Martinez","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.ymthe.2026.01.006_bib18","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1038\/sj.gt.3302801","article-title":"T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery","volume":"13","author":"Swan","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2026.01.006_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191709","article-title":"Editing of the human TRIM5 gene to introduce mutations with the potential to inhibit HIV-1","volume":"13","author":"Dufour","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2026.01.006_bib20","doi-asserted-by":"crossref","first-page":"11117","DOI":"10.1128\/JVI.01046-08","article-title":"Mode of transmission affects the sensitivity of human immunodeficiency virus type 1 to restriction by rhesus TRIM5alpha","volume":"82","author":"Richardson","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.01.006_bib21","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/mt.2014.52","article-title":"Stabilized human TRIM5alpha protects human T cells from HIV-1 infection","volume":"22","author":"Richardson","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.01.006_bib22","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144486","article-title":"CCR5-edited CD4 T cells augment HIV-specific immunity to enable post rebound control of HIV replication","volume":"131","author":"Tebas","year":"2021","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.ymthe.2026.01.006_bib23","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1089\/hum.1998.9.16-2407","article-title":"A controlled, Phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNA","volume":"9","author":"Wong-Staal","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2026.01.006_bib24","first-page":"97","article-title":"HIV-1 coreceptors and their inhibitors","volume":"303","author":"Ray","year":"2006","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.ymthe.2026.01.006_bib25","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006866","article-title":"HIV: cell binding and entry","volume":"2","author":"Wilen","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ymthe.2026.01.006_bib26","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3390\/v11080705","article-title":"Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41","volume":"11","author":"Pu","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2026.01.006_bib27","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1128\/JVI.75.6.3038-3042.2001","article-title":"Membrane-anchored peptide inhibits human immunodeficiency virus entry","volume":"75","author":"Hildinger","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.01.006_bib28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clim.2005.02.019","article-title":"Suppression of HIV-1 infection in primary CD4 T cells transduced with a self-inactivating lentiviral vector encoding a membrane expressed gp41-derived fusion inhibitor","volume":"115","author":"Perez","year":"2005","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ymthe.2026.01.006_bib29","doi-asserted-by":"crossref","first-page":"15613","DOI":"10.1073\/pnas.95.26.15613","article-title":"Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target","volume":"95","author":"Chan","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.01.006_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005983","article-title":"Potent and Broad Inhibition of HIV-1 by a Peptide from the gp41 Heptad Repeat-2 Domain Conjugated to the CXCR4 Amino Terminus","volume":"12","author":"Leslie","year":"2016","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2026.01.006_bib31","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1084\/jem.20030648","article-title":"HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse","volume":"199","author":"Jolly","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2026.01.006_bib32","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1038\/s41591-020-1039-5","article-title":"Dual CD4-based CAR T cells with distinct costimulatory domains mitigate HIV pathogenesis in vivo","volume":"26","author":"Maldini","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.01.006_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav5685","article-title":"Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model","volume":"11","author":"Anthony-Gonda","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.01.006_bib34","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jcyt.2017.11.001","article-title":"Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose Glycans of gp120 optimized for anti-human immunodeficiency virus potency and breadth with minimal immunogenicity","volume":"20","author":"Ghanem","year":"2018","journal-title":"Cytotherapy"},{"key":"10.1016\/j.ymthe.2026.01.006_bib35","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.161698","article-title":"In vivo killing of primary HIV-infected cells by peripheral-injected early memory-enriched anti-HIV duoCAR T cells","volume":"7","author":"Anthony-Gonda","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2026.01.006_bib36","doi-asserted-by":"crossref","first-page":"9911","DOI":"10.1128\/JVI.00533-09","article-title":"Derivation and characterization of a simian immunodeficiency virus SIVmac239 variant with tropism for CXCR4","volume":"83","author":"Del Prete","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.01.006_bib37","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/AAC.46.6.1896-1905.2002","article-title":"Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy","volume":"46","author":"Wei","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ymthe.2026.01.006_bib38","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/s41467-025-56116-1","article-title":"Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies","volume":"16","author":"Gunst","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.01.006_bib39","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-019-0898-8","article-title":"A quantitative approach for measuring the reservoir of latent HIV-1 proviruses","volume":"566","author":"Bruner","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.01.006_bib40","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nm1520","article-title":"CD8+ T-cell responses to different HIV proteins have discordant associations with viral load","volume":"13","author":"Kiepiela","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.01.006_bib41","doi-asserted-by":"crossref","first-page":"9928","DOI":"10.1073\/pnas.1601278113","article-title":"Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices","volume":"113","author":"Wescott","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.01.006_bib42","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.ymthe.2020.05.012","article-title":"HIV-Resistant and HIV-Specific CAR-Modified CD4(+) T Cells Mitigate HIV Disease Progression and Confer CD4(+) T Cell Help In Vivo","volume":"28","author":"Maldini","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.01.006_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006613","article-title":"Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptor","volume":"13","author":"Leibman","year":"2017","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2026.01.006_bib44","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/mt.2015.70","article-title":"Engineering T Cells to Functionally Cure HIV-1 Infection","volume":"23","author":"Leibman","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.01.006_bib45","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1128\/JVI.07062-11","article-title":"Vpu Augments the Initial Burst Phase of HIV-1 Propagation and Downregulates BST2 and CD4 in Humanized Mice","volume":"86","author":"Sato","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.01.006_bib46","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nature06553","article-title":"Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu","volume":"451","author":"Neil","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.01.006_bib47","doi-asserted-by":"crossref","first-page":"12185","DOI":"10.1128\/JVI.01447-10","article-title":"Cell-Cell Spread of Human Immunodeficiency Virus Type 1 Overcomes Tetherin\/BST-2-Mediated Restriction in T cells","volume":"84","author":"Jolly","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.01.006_bib48","doi-asserted-by":"crossref","first-page":"9040","DOI":"10.1073\/pnas.1820333116","article-title":"Mutations in the HIV-1 envelope glycoprotein can broadly rescue blocks at multiple steps in the virus replication cycle","volume":"116","author":"Van Duyne","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.01.006_bib49","doi-asserted-by":"crossref","first-page":"8499","DOI":"10.1128\/JVI.00424-12","article-title":"Vpu-deficient HIV strains stimulate innate immune signaling responses in target cells","volume":"86","author":"Doehle","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.01.006_bib50","article-title":"CXCR4 orchestrates the TOX-programmed exhausted phenotype of CD8+ T cells via JAK2\/STAT3 pathway","volume":"4","author":"Cao","year":"2024","journal-title":"Cell Genom."},{"key":"10.1016\/j.ymthe.2026.01.006_bib51","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1634\/stemcells.2003-0196","article-title":"CXCR4-Transgene Expression Significantly Improves Marrow Engraftment of Cultured Hematopoietic Stem Cells","volume":"22","author":"Brenner","year":"2004","journal-title":"Stem Cells"},{"key":"10.1016\/j.ymthe.2026.01.006_bib52","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.immuni.2006.06.015","article-title":"CXCR4 Physically Associates with the T Cell Receptor to Signal in T Cells","volume":"25","author":"Kumar","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2026.01.006_bib53","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/ni1251","article-title":"Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells","volume":"6","author":"Dar","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2026.01.006_bib54","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41577-018-0042-2","article-title":"CAR T cells for infection, autoimmunity and allotransplantation","volume":"18","author":"Maldini","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2026.01.006_bib55","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0022-1759(02)00423-4","article-title":"Optimized determination of T cell epitope responses","volume":"274","author":"Roederer","year":"2003","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ymthe.2026.01.006_bib56","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1084\/jem.187.7.1139","article-title":"Productive infection of neonatal CD8+ T lymphocytes by HIV-1","volume":"187","author":"Yang","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2026.01.006_bib57","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jim.2015.04.030","article-title":"An imaging flow cytometry-based approach to measuring the spatiotemporal calcium mobilisation in activated T cells","volume":"423","author":"Cerveira","year":"2015","journal-title":"J. Immunol. Methods"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626000067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626000067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T20:35:37Z","timestamp":1776371737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626000067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1525001626000067"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.01.006","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical trial results provide the rationale to protect dual HIV-specific T cells with a signaling-defective HIV fusion inhibitor","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}